MODERNA INC (0QF.DE) Stock Fundamental Analysis
Europe - FRA:0QF - US60770K1079 - Common Stock
21.67 EUR
+0.87 (+4.16%)
We assign a fundamental rating of 3 out of 10 to 0QF. 0QF was compared to 74 industry peers in the Biotechnology industry. The financial health of 0QF is average, but there are quite some concerns on its profitability. 0QF is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
0QF had negative earnings in the past year.
In the past year 0QF has reported a negative cash flow from operations.
In multiple years 0QF reported negative net income over the last 5 years.
In multiple years 0QF reported negative operating cash flow during the last 5 years.
1.2 Ratios
With a Return On Assets value of -24.17%, 0QF perfoms like the industry average, outperforming 51.35% of the companies in the same industry.
0QF has a better Return On Equity (-30.89%) than 63.51% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -24.17% | ||
| ROE | -30.89% | ||
| ROIC | N/A |
ROA(3y)-6.14%
ROA(5y)4.17%
ROE(3y)-7.66%
ROE(5y)6.83%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
0QF has a better Gross Margin (68.32%) than 60.81% of its industry peers.
0QF's Gross Margin has declined in the last couple of years.
0QF does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 68.32% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.55%
GM growth 5YN/A
2. Health
2.1 Basic Checks
0QF does not have a ROIC to compare to the WACC, probably because it is not profitable.
0QF has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, 0QF has more shares outstanding
The debt/assets ratio for 0QF has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 3.07 indicates that 0QF is not in any danger for bankruptcy at the moment.
0QF has a better Altman-Z score (3.07) than 75.68% of its industry peers.
0QF has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
0QF's Debt to Equity ratio of 0.00 is amongst the best of the industry. 0QF outperforms 86.49% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 3.07 |
ROIC/WACCN/A
WACC8.62%
2.3 Liquidity
0QF has a Current Ratio of 3.93. This indicates that 0QF is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.93, 0QF is in the better half of the industry, outperforming 72.97% of the companies in the same industry.
0QF has a Quick Ratio of 3.77. This indicates that 0QF is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of 0QF (3.77) is better than 74.32% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.93 | ||
| Quick Ratio | 3.77 |
3. Growth
3.1 Past
0QF shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -38.66%.
0QF shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -52.75%.
The Revenue has been growing by 122.01% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-38.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1800%
Revenue 1Y (TTM)-52.75%
Revenue growth 3Y-44.04%
Revenue growth 5Y122.01%
Sales Q2Q%-45.44%
3.2 Future
0QF is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.26% yearly.
Based on estimates for the next years, 0QF will show a quite strong growth in Revenue. The Revenue will grow by 17.50% on average per year.
EPS Next Y-7.31%
EPS Next 2Y7.12%
EPS Next 3Y12.73%
EPS Next 5Y20.26%
Revenue Next Year-41%
Revenue Next 2Y-19.3%
Revenue Next 3Y-7.47%
Revenue Next 5Y17.5%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
0QF reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for 0QF. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
0QF's earnings are expected to grow with 12.73% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y7.12%
EPS Next 3Y12.73%
5. Dividend
5.1 Amount
No dividends for 0QF!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:0QF (11/11/2025, 4:47:02 PM)
21.67
+0.87 (+4.16%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners74.95%
Inst Owner ChangeN/A
Ins Owners2.55%
Ins Owner ChangeN/A
Market Cap8.46B
Revenue(TTM)3.24B
Net Income(TTM)-2.90B
Analysts55.33
Price Target38.26 (76.56%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)25.41%
Min EPS beat(2)21.22%
Max EPS beat(2)29.6%
EPS beat(4)3
Avg EPS beat(4)36.52%
Min EPS beat(4)-6.26%
Max EPS beat(4)101.54%
EPS beat(8)6
Avg EPS beat(8)-7.95%
EPS beat(12)8
Avg EPS beat(12)0.84%
EPS beat(16)11
Avg EPS beat(16)4.98%
Revenue beat(2)1
Avg Revenue beat(2)11.48%
Min Revenue beat(2)-0.3%
Max Revenue beat(2)23.26%
Revenue beat(4)3
Avg Revenue beat(4)17.36%
Min Revenue beat(4)-0.3%
Max Revenue beat(4)46.04%
Revenue beat(8)7
Avg Revenue beat(8)31.8%
Revenue beat(12)9
Avg Revenue beat(12)25.64%
Revenue beat(16)12
Avg Revenue beat(16)20.85%
PT rev (1m)-4.45%
PT rev (3m)-5.52%
EPS NQ rev (1m)-1.97%
EPS NQ rev (3m)-7.45%
EPS NY rev (1m)0.21%
EPS NY rev (3m)3.69%
Revenue NQ rev (1m)-2.17%
Revenue NQ rev (3m)-8.51%
Revenue NY rev (1m)-1.27%
Revenue NY rev (3m)-8.72%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 3.18 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 1.04 | ||
| P/tB | 1.05 | ||
| EV/EBITDA | N/A |
EPS(TTM)-6.97
EYN/A
EPS(NY)-6.84
Fwd EYN/A
FCF(TTM)-7.74
FCFYN/A
OCF(TTM)-5.97
OCFYN/A
SpS6.81
BVpS20.8
TBVpS20.58
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -24.17% | ||
| ROE | -30.89% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 68.32% | ||
| FCFM | N/A |
ROA(3y)-6.14%
ROA(5y)4.17%
ROE(3y)-7.66%
ROE(5y)6.83%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.55%
GM growth 5YN/A
F-Score4
Asset Turnover0.26
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 386.06% | ||
| Cap/Sales | 26.09% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.93 | ||
| Quick Ratio | 3.77 | ||
| Altman-Z | 3.07 |
F-Score4
WACC8.62%
ROIC/WACCN/A
Cap/Depr(3y)261.63%
Cap/Depr(5y)224.68%
Cap/Sales(3y)14.96%
Cap/Sales(5y)10.95%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-38.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1800%
EPS Next Y-7.31%
EPS Next 2Y7.12%
EPS Next 3Y12.73%
EPS Next 5Y20.26%
Revenue 1Y (TTM)-52.75%
Revenue growth 3Y-44.04%
Revenue growth 5Y122.01%
Sales Q2Q%-45.44%
Revenue Next Year-41%
Revenue Next 2Y-19.3%
Revenue Next 3Y-7.47%
Revenue Next 5Y17.5%
EBIT growth 1Y35.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-0.33%
EBIT Next 3Y14.92%
EBIT Next 5Y18.99%
FCF growth 1Y-364.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1093.36%
OCF growth 3YN/A
OCF growth 5YN/A
MODERNA INC / 0QF.DE FAQ
Can you provide the ChartMill fundamental rating for MODERNA INC?
ChartMill assigns a fundamental rating of 3 / 10 to 0QF.DE.
What is the valuation status for 0QF stock?
ChartMill assigns a valuation rating of 0 / 10 to MODERNA INC (0QF.DE). This can be considered as Overvalued.
What is the profitability of 0QF stock?
MODERNA INC (0QF.DE) has a profitability rating of 2 / 10.
What is the expected EPS growth for MODERNA INC (0QF.DE) stock?
The Earnings per Share (EPS) of MODERNA INC (0QF.DE) is expected to decline by -7.31% in the next year.